KR102281853B1 - 열겔화 인공 누액 - Google Patents

열겔화 인공 누액 Download PDF

Info

Publication number
KR102281853B1
KR102281853B1 KR1020207004982A KR20207004982A KR102281853B1 KR 102281853 B1 KR102281853 B1 KR 102281853B1 KR 1020207004982 A KR1020207004982 A KR 1020207004982A KR 20207004982 A KR20207004982 A KR 20207004982A KR 102281853 B1 KR102281853 B1 KR 102281853B1
Authority
KR
South Korea
Prior art keywords
viscosity
composition
present
aqueous
examples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020207004982A
Other languages
English (en)
Korean (ko)
Other versions
KR20200020999A (ko
Inventor
다케시 야마무라
아야카 야마무로
에미 이즈쿠라
모토 기무라
도모히로 오쓰카
Original Assignee
와카모토 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 와카모토 세이야꾸 가부시끼가이샤 filed Critical 와카모토 세이야꾸 가부시끼가이샤
Publication of KR20200020999A publication Critical patent/KR20200020999A/ko
Application granted granted Critical
Publication of KR102281853B1 publication Critical patent/KR102281853B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
KR1020207004982A 2017-04-25 2018-04-25 열겔화 인공 누액 Expired - Fee Related KR102281853B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JPJP-P-2017-086512 2017-04-25
JP2017086512 2017-04-25
JP2017249891 2017-12-26
JPJP-P-2017-249891 2017-12-26
KR1020197026971A KR102083253B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액
PCT/JP2018/016854 WO2018199180A1 (ja) 2017-04-25 2018-04-25 熱ゲル化人工涙液

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197026971A Division KR102083253B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Publications (2)

Publication Number Publication Date
KR20200020999A KR20200020999A (ko) 2020-02-26
KR102281853B1 true KR102281853B1 (ko) 2021-07-23

Family

ID=63919901

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020207004982A Expired - Fee Related KR102281853B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액
KR1020197026971A Expired - Fee Related KR102083253B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197026971A Expired - Fee Related KR102083253B1 (ko) 2017-04-25 2018-04-25 열겔화 인공 누액

Country Status (16)

Country Link
US (2) US10532026B2 (https=)
EP (1) EP3593806B1 (https=)
JP (2) JP6473274B1 (https=)
KR (2) KR102281853B1 (https=)
CN (2) CN110913867B (https=)
AU (1) AU2018257301B2 (https=)
BR (1) BR112019018368B1 (https=)
CA (1) CA3025567C (https=)
ES (1) ES2912289T3 (https=)
MX (2) MX379302B (https=)
MY (2) MY196565A (https=)
PH (1) PH12019502335A1 (https=)
RU (1) RU2710366C1 (https=)
SG (1) SG11201909170QA (https=)
TW (1) TWI733019B (https=)
WO (1) WO2018199180A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117137866A (zh) * 2018-02-28 2023-12-01 参天制药株式会社 含有地夸磷索及阳离子性聚合物的眼科用组合物
AU2019228913C1 (en) * 2018-03-01 2024-10-31 Ishihara Sangyo Kaisha, Ltd. Pharmaceutical composition with excellent storage stability
ES2994624T3 (en) * 2019-02-27 2025-01-27 Santen Pharmaceutical Co Ltd Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003095924A (ja) * 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2125060C (en) * 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears
JP3450805B2 (ja) 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
GB0210794D0 (en) * 2002-05-10 2002-06-19 Chart Heat Exchangers Ltd Heat exchangers
JP4263456B2 (ja) 2002-03-18 2009-05-13 わかもと製薬株式会社 ヒアルロン酸含有熱ゲル化製剤
JP4263418B2 (ja) * 2002-03-18 2009-05-13 わかもと製薬株式会社 熱ゲル化人工涙液
JP4947977B2 (ja) 2003-10-31 2012-06-06 わかもと製薬株式会社 可逆性熱ゲル化水性組成物
JP5649261B2 (ja) * 2004-05-07 2015-01-07 ロート製薬株式会社 高粘度点眼剤
JP5661981B2 (ja) * 2004-11-26 2015-01-28 大正製薬株式会社 眼科用剤
EP2172224A4 (en) * 2007-06-26 2013-01-16 Wakamoto Pharma Co Ltd AQUEOUS COMPOSITION

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003095924A (ja) * 2001-07-16 2003-04-03 Wakamoto Pharmaceut Co Ltd 熱ゲル化人工涙液

Also Published As

Publication number Publication date
JP2019104740A (ja) 2019-06-27
AU2018257301B2 (en) 2019-10-31
CN110913867B (zh) 2021-06-11
CN113332233A (zh) 2021-09-03
TW201842900A (zh) 2018-12-16
EP3593806B1 (en) 2022-03-30
MX2018014935A (es) 2019-04-09
MX379302B (es) 2025-03-11
BR112019018368A2 (pt) 2020-04-07
TWI733019B (zh) 2021-07-11
KR20190110624A (ko) 2019-09-30
AU2018257301A1 (en) 2019-08-22
JP6736705B2 (ja) 2020-08-05
WO2018199180A1 (ja) 2018-11-01
MY196323A (en) 2023-03-24
EP3593806A1 (en) 2020-01-15
PH12019502335A1 (en) 2020-09-14
US20200121592A1 (en) 2020-04-23
CA3025567C (en) 2019-10-22
CA3025567A1 (en) 2018-11-01
JPWO2018199180A1 (ja) 2019-06-27
CN113332233B (zh) 2022-02-25
US10532026B2 (en) 2020-01-14
RU2710366C1 (ru) 2019-12-26
US11096889B2 (en) 2021-08-24
SG11201909170QA (en) 2019-11-28
ES2912289T3 (es) 2022-05-25
KR20200020999A (ko) 2020-02-26
BR112019018368B1 (pt) 2021-03-02
EP3593806A4 (en) 2020-03-25
KR102083253B1 (ko) 2020-03-02
MY196565A (en) 2023-04-19
US20180360746A1 (en) 2018-12-20
JP6473274B1 (ja) 2019-02-20
CN110913867A (zh) 2020-03-24

Similar Documents

Publication Publication Date Title
JP5340149B2 (ja) 水性組成物
JP6452283B2 (ja) 眼の異物感改善剤
EA034839B1 (ru) Офтальмологический раствор
EP3213763B1 (en) Ophthalmic composition comprising cyclosporine and trehalose
KR20220052971A (ko) 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
KR102281853B1 (ko) 열겔화 인공 누액
WO2020175525A1 (ja) ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物
JP5649261B2 (ja) 高粘度点眼剤
KR20230041692A (ko) 고안압증 및 녹내장의 치료 및 예방을 위한 히알루론산계 제제
KR102268002B1 (ko) 효과 지속성 점안제 조성물
JP7358526B2 (ja) 向上した眼の快適性を提供する組成物
JP2014167034A (ja) 高粘度点眼剤
EP4454639A1 (en) Ophthalmic composition comprising carbomer and taurine
RU2806029C2 (ru) Композиции, обеспечивающие повышенный комфорт для глаз
HK40017178A (en) Thermogelling artificial tears
HK40017178B (en) Thermogelling artificial tears
JP2020040896A (ja) 摩擦によるストレス低減剤

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
A302 Request for accelerated examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PA0302 Request for accelerated examination

St.27 status event code: A-1-2-D10-D17-exm-PA0302

St.27 status event code: A-1-2-D10-D16-exm-PA0302

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20250721

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20250721